Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Neyts

Showing results (11-20 of 587) with videos related to

Pageof 59
Sort By:
Reviews in Medical Virology|August 31, 2004
Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infectionsErik De Clercq, Johan Neyts
Current Opinion in Pharmacology|July 2, 2016
Towards antiviral therapies for treating dengue virus infectionsSuzanne Jf Kaptein, Johan Neyts
Trends in Pharmacological Sciences|May 8, 2007
Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic interventionErik De Clercq, Johan Neyts
Current Opinion in Virology|March 24, 2012
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of actionJan Paeshuyse, Kai Dallmeier, Johan Neyts
Antiviral Research|June 30, 2015
Towards antivirals against chikungunya virusRana Abdelnabi, Johan Neyts, Leen Delang
Antiviral Research|March 11, 2018
Favipiravir as a potential countermeasure against neglected and emerging RNA virusesLeen Delang, Rana Abdelnabi, Johan Neyts
Intensive Care Medicine|May 25, 2021
COVID-19 and the intensive care unit: vaccines to the rescueKai Dallmeier, Geert Meyfroidt, Johan Neyts
Current Opinion in Infectious Diseases|November 3, 2015
The future of antivirals: broad-spectrum inhibitorsYannick Debing, Johan Neyts, Leen Delang
Viruses|October 14, 2011
Antiviral therapy for hepatitis C virus: beyond the standard of careLeen Delang, Lotte Coelmont, Johan Neyts
Antiviral Research|March 12, 2014
Are statins a viable option for the treatment of infections with the hepatitis C virus?Ben Verpaalen, Johan Neyts, Leen Delang
Pageof 59

Showing results (11-20 of 587) with videos related to

Sort By:
Pageof 59
Reviews in Medical Virology|August 31, 2004
Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infectionsErik De Clercq, Johan Neyts
Current Opinion in Pharmacology|July 2, 2016
Towards antiviral therapies for treating dengue virus infectionsSuzanne Jf Kaptein, Johan Neyts
Trends in Pharmacological Sciences|May 8, 2007
Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic interventionErik De Clercq, Johan Neyts
Current Opinion in Virology|March 24, 2012
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of actionJan Paeshuyse, Kai Dallmeier, Johan Neyts
Antiviral Research|June 30, 2015
Towards antivirals against chikungunya virusRana Abdelnabi, Johan Neyts, Leen Delang
Antiviral Research|March 11, 2018
Favipiravir as a potential countermeasure against neglected and emerging RNA virusesLeen Delang, Rana Abdelnabi, Johan Neyts
Intensive Care Medicine|May 25, 2021
COVID-19 and the intensive care unit: vaccines to the rescueKai Dallmeier, Geert Meyfroidt, Johan Neyts
Current Opinion in Infectious Diseases|November 3, 2015
The future of antivirals: broad-spectrum inhibitorsYannick Debing, Johan Neyts, Leen Delang
Viruses|October 14, 2011
Antiviral therapy for hepatitis C virus: beyond the standard of careLeen Delang, Lotte Coelmont, Johan Neyts
Antiviral Research|March 12, 2014
Are statins a viable option for the treatment of infections with the hepatitis C virus?Ben Verpaalen, Johan Neyts, Leen Delang
Pageof 59